Selux Diagnostics
Aleksandar Vacic is the President and Co-founder of SeLux Diagnostics, Inc., a company dedicated to providing personalized diagnostic information to combat antibiotic-resistant superbugs. Prior experience includes serving as Senior Engineer and Cell Processing Lead at 1366 Technologies, Inc., where Aleksandar successfully led the R&D of solar cell manufacturing and built small-scale production to achieve cost-efficiency. Aleksandar earned a PhD in Engineering and Applied Sciences from Yale University, focusing on Quantitative Semiconductor Nanosensors, and has held roles as a Teaching Fellow and Technology Consultant at the Yale Entrepreneurial Institute. Educational background includes a degree in Engineering Physics from the University of Belgrade and a research fellowship at the Weizmann Institute of Science.
This person is not in any offices
Selux Diagnostics
Selux Diagnostics is developing a Next-Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital-acquired infections, and help combat the global antibiotic resistance epidemic.